Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Inova Schar Cancer Institute
mi
from
Fairfax, VA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Treatment Centers of America-Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sutter Cancer Research Consortium
mi
from
San Francisco, CA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
A Study of Parsaclisib in Combination With Ruxolitinib in Subjects With Myelofibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology/Hematology Care, Inc. and Oncology Hematology Care Clinical Trials, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
A Study of Parsaclisib in Combination With Ruxolitinib in Subjects With Myelofibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center- MAIN
mi
from
New York, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology Clinical Trial
Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Sydney,
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Comprehensive Cancer Center (UAB CCC)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Baylor Scott and White University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Oncology-Selinsgrove
mi
from
Selinsgrove, PA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Desoto
mi
from
Southhaven, MS
Click here to add this to my saved trials
Hematology Clinical Trial
Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Edwards-Elmhurst Memorial
mi
from
Elmhurst, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Sir Charles Gairdner Hospital
mi
from
Nedlands,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Oncology Clinical Trial
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status: Enrolling
Updated: 7/29/2015
Philadelphia CyberKnife
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Acquired Hemophilia A Clinical Trial
Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A
Status: Enrolling, Phase
Updated: 3/22/2018
Blood Center of Southeast Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Status: Enrolling, Phase III
Updated: 3/9/2018
Wayne State University - Karmanos Cacner Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Indiana Blood and Marrow Institute Indiana Blood and Marrow Trans
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
McGovern Medical School at the University of Texas Health
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University Medical Center, Clinical Trials Center Division Hematology/Oncology
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
University of Rochester Medical Center Univ of Rochester (7)
mi
from
Rochester, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Veterans Affairs Puget Sound Health Care System VAMC Seattle, WA Divison
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Pennsylvania Abramson Cancer Center Clinical Research Unit
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission
Status: Enrolling, Phase III
Updated: 12/31/1969
Site US10024
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Sylvester at Deerfield Beach
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Altman Clinical and Translational Research Institute
mi
from
La Jolla, CA
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
UZ Leuven
mi
from
Leuven,
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic Hospital-Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Biomarker-Directed Phase 2 Trial of SY-1425 in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Biomarker-Directed Phase 2 Trial of SY-1425 in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Biomarker-Directed Phase 2 Trial of SY-1425 in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Peoria, IL
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes
Status: Enrolling, Phase I
Updated: 12/31/1969
Washington University: Siteman Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hemophilia A Clinical Trial
BAX 855 Previously Untreated Patient (PUP)
Status: Enrolling, Phase III
Updated: 4/19/2018
Bleeding and Clotting Dis.Inst.
mi
from
Peoria, IL
Click here to add this to my saved trials
Chronic Graft Versus Host Disease Clinical Trial
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Subjects With New Onset cGVHD
Status: Enrolling, Phase III
Updated: 12/31/1969
Childens Hospital Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Chronic Graft Versus Host Disease Clinical Trial
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Subjects With New Onset cGVHD
Status: Enrolling, Phase III
Updated: 12/31/1969
St Vincent's Hospital
mi
from
Darlinghurst,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Transplantation of Ex Vivo Expanded, UCB-derived, Stem & Progenitor Cells vs. Unmanipulated UCB for HM Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
City of Hope
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Graft vs Host Disease Clinical Trial
Study of PRO 140 for Prophylaxis of Acute GVHD in Patients Undergoing RIC Allogenic Stem-Cell Transplantaton
Status: Enrolling, Phase II
Updated: 12/31/1969
West Virginia University Medicine
mi
from
Morgantown, WV
Click here to add this to my saved trials
Acute Myeloid Leukemia (AML) Clinical Trial
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke Univ Medical Center /ID# 154106
mi
from
Durham, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
A Randomized Multicenter Study for Isolated Skin Vasculitis
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Joseph's Healthcare
mi
from
Hamilton,
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University Division of Hematology
mi
from
Saint Louis, MO
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ames, IA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Avon, IN
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bristol, VA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Covington, LA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Danville, PA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dunmore, PA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
East Setauket, NY
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Florham Park, NJ
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Grand Island, NE
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lancaster, SC
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
McKinney, TX
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rockport, ME
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tualatin, OR
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling, Phase
Updated: 12/31/1969
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)
Status: Enrolling, Phase
Updated: 12/31/1969
Georgia Cancer Center at Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Elotuzumab, Lenalidomide and Dexamethasone (ERd) in the Induction, Consolidation and Maintenance Treatment of Transplant-Eligible, Newly Diagnosed Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
HCA Midwest Health/Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Mobile Health Device Study for Myeloma Patients
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
MMRF Molecular Profiling Protocol
Status: Enrolling, Phase
Updated: 12/31/1969
Princess Margaret Cancer Centre
mi
from
Toronto,
Click here to add this to my saved trials
Hematology Clinical Trial
Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
Weill Cornell Medical Centers
mi
from
New York, NY
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mid Florida Hematology and Oncolcogy Center
mi
from
Orange City, FL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
Innovation Medical Research Center
mi
from
Palmetto Bay, FL
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
Healthcare Research Network III, LLC
mi
from
Tinley Park, IL
Click here to add this to my saved trials
Hemophilia A Clinical Trial
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Status: Enrolling, Phase
Updated: 3/26/2018
Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology Clinical Trial
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Duke Clin Rsch Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Oklahoma Health Sciences Center, Stephenson Cancer Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado - Aurora Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Indiana University (IU) Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Wake Forest Baptist Medical Center - Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Amyloidosis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Wake Forest University Health Sciences - Cardiovascular Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ
Status: Enrolling, Phase
Updated: 12/31/1969
Fundación de Hemofilia de Salta
mi
from
Salta,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
San Jorge Children's Hospital
mi
from
San Juan,
Click here to add this to my saved trials
Bacteremia Clinical Trial
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
Status: Enrolling, Phase I
Updated: 12/31/1969
Chungnam National University Hospital
mi
from
Daejeon,
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Pontchartrain Cancer Center (Research Location)
mi
from
Covington, LA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Center of Medical Research
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Hematology Clinical Trial
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Paroxysmal Nocturnal Hemoglobinuria (PNH) Clinical Trial
Extension Study of RA101495 for Patients With PNH Who Have Completed a RA101495 Clinical Study
Status: Enrolling, Phase II
Updated: 2/22/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials